Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

A New Zealand shell company was used to wire money in a healthcare fraud scheme worth more than half a billion dollars.

Two bipartisan health care bills to fix price transparency failed to gain traction in the narrowed-down continuing resolution ...

A simple blood draw to test your body for more than 50 types of cancer is considered promising for early cancer detection, though there is concern about its rel ...

After the passing of the 39th President of the United States, Jimmy Carter, we take a look back at 10 defining moments from ...

A record number of Illinois residents have signed up for Affordable Care Act health insurance plans for this year — amid uncertainties about the future of tax credits that lower the cost of those ...

A Virginia hospital is facing federal criminal charges over what prosecutors say was an extended scheme to profit from a high ...

With the leadership of state associations, pharmacists are poised to make 2025 a landmark year for advocacy and action. State legislatures will serve as the proving ground for healthcare innovation, ...

Speaker of the House Mike Johnson told Axios that Republicans are discussing work requirements as part of a potential Medicaid overhaul.

As Trump’s inauguration nears, Fetterman has shown the most receptiveness — and sometimes enthusiasm — to work with Trump of ...

Pennsylvania Senator John Fetterman is bucking party lines to meet with President-elect Donald Trump in Mar-a-Lago.

During his time in Washington, the late Rep. Donald Payne Jr. (D-Newark) was one of Congress’s chief advocates on an issue that rarely breaks into the ...